Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles
<p>Abstract</p> <p>This commentary discusses a study on measurements of matrix metalloproteinase 9 (MMP-9) in serum of pseudoxanthoma elasticum patients recently published in Journal of Molecular Medicine. This study can be considered the typical "obstacle" to effective t...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-10-01
|
Series: | Journal of Translational Medicine |
Online Access: | http://www.translational-medicine.com/content/7/1/87 |
id |
doaj-055e8562ca9b4d96afd82b98a5e9dc53 |
---|---|
record_format |
Article |
spelling |
doaj-055e8562ca9b4d96afd82b98a5e9dc532020-11-25T00:36:39ZengBMCJournal of Translational Medicine1479-58762009-10-01718710.1186/1479-5876-7-87Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principlesMannello FerdinandoJung KlausLein Michael<p>Abstract</p> <p>This commentary discusses a study on measurements of matrix metalloproteinase 9 (MMP-9) in serum of pseudoxanthoma elasticum patients recently published in Journal of Molecular Medicine. This study can be considered the typical "obstacle" to effective translational medicine as previously documented in <it>JTM </it>journal. Although serum has been frequently proven as inappropriate sample for determining numerous circulating MMPs, among them MMP-9, there are over and over again studies, as in this case, that measure MMP-9 in serum. Comparative measurements in serum and plasma samples demonstrated higher concentrations for MMP-9 in serum due to the additional release from leukocytes and platelets following the coagulation/fibrinolysis process. From this example it can be concluded that translating basic research discoveries into clinical tools needs a more intensive exchange between basic biomedical research and clinical scientists already in an early stage. Otherwise a lost of translation, as discussed in <it>JTM </it>journal, seems to be inevitable.</p> http://www.translational-medicine.com/content/7/1/87 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mannello Ferdinando Jung Klaus Lein Michael |
spellingShingle |
Mannello Ferdinando Jung Klaus Lein Michael Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles Journal of Translational Medicine |
author_facet |
Mannello Ferdinando Jung Klaus Lein Michael |
author_sort |
Mannello Ferdinando |
title |
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles |
title_short |
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles |
title_full |
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles |
title_fullStr |
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles |
title_full_unstemmed |
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles |
title_sort |
translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles |
publisher |
BMC |
series |
Journal of Translational Medicine |
issn |
1479-5876 |
publishDate |
2009-10-01 |
description |
<p>Abstract</p> <p>This commentary discusses a study on measurements of matrix metalloproteinase 9 (MMP-9) in serum of pseudoxanthoma elasticum patients recently published in Journal of Molecular Medicine. This study can be considered the typical "obstacle" to effective translational medicine as previously documented in <it>JTM </it>journal. Although serum has been frequently proven as inappropriate sample for determining numerous circulating MMPs, among them MMP-9, there are over and over again studies, as in this case, that measure MMP-9 in serum. Comparative measurements in serum and plasma samples demonstrated higher concentrations for MMP-9 in serum due to the additional release from leukocytes and platelets following the coagulation/fibrinolysis process. From this example it can be concluded that translating basic research discoveries into clinical tools needs a more intensive exchange between basic biomedical research and clinical scientists already in an early stage. Otherwise a lost of translation, as discussed in <it>JTM </it>journal, seems to be inevitable.</p> |
url |
http://www.translational-medicine.com/content/7/1/87 |
work_keys_str_mv |
AT mannelloferdinando translatingmolecularmedicineintoclinicaltoolsdoomedtofailbyneglectingbasicpreanalyticalprinciples AT jungklaus translatingmolecularmedicineintoclinicaltoolsdoomedtofailbyneglectingbasicpreanalyticalprinciples AT leinmichael translatingmolecularmedicineintoclinicaltoolsdoomedtofailbyneglectingbasicpreanalyticalprinciples |
_version_ |
1725304302882258944 |